1620 Investment Advisors’s Chemours CC Stock Holding History

1620 Investment Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40	Closed	-$664	–	687
2024 Q4	$676	Hold	40	–	–	﹤0.01%	661
2024 Q3	$813	Hold	40	–	–	﹤0.01%	650
2024 Q2	$903	Buy	+40	New	+$1.05K	﹤0.01%	573

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

1620 Investment Advisors's CC Position: Q1 2025 in Review

1620 Investment Advisors sold out of Chemours (CC) in Q1 2025, closing a stake of 40 shares — an estimated $664 sold.

1620 Investment Advisors first reported a position in CC in Q2 2024 and held it in 3 quarters. The position peaked at $903 in Q2 2024. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

1620 Investment Advisors reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
1620 Investment Advisors sold 40 Chemours shares in Q1 2025, an estimated $664.
1620 Investment Advisors first reported a position in Chemours in Q2 2024 and held it in 3 quarters.
1620 Investment Advisors's Chemours position peaked at $903 in Q2 2024.
419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on 1620 Investment Advisors's 13F filing for Q1 2025, filed 14 May 2025.